Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.54 USD | -1.84% | -3.87% | -13.22% |
May. 30 | Day One Biopharmaceuticals Sells Priority Review Voucher for $108 Million | MT |
May. 20 | BrightSpring Health Services Says Onco360 Selected as Pharmacy Partner for Ojemda | MT |
Financials (USD)
Sales 2024 * | 14.91M | Sales 2025 * | 82.05M | Capitalization | 1.12B |
---|---|---|---|---|---|
Net income 2024 * | -237M | Net income 2025 * | -202M | EV / Sales 2024 * | 61.7 x |
Net cash position 2024 * | 196M | Net cash position 2025 * | 212M | EV / Sales 2025 * | 11 x |
P/E ratio 2024 * |
-4.73
x | P/E ratio 2025 * |
-5.99
x | Employees | 174 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.28% |
Latest transcript on Day One Biopharmaceuticals, Inc.
1 day | -1.84% | ||
1 week | -3.87% | ||
Current month | -4.52% | ||
1 month | -20.81% | ||
3 months | -16.37% | ||
6 months | +7.83% | ||
Current year | -13.22% |
Managers | Title | Age | Since |
---|---|---|---|
Samuel Blackman
FOU | Founder | 55 | 18-10-31 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 20-08-31 |
Charles York
DFI | Director of Finance/CFO | 47 | 21-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 21-08-16 |
Natalie Holles
BRD | Director/Board Member | 51 | 21-01-31 |
John Josey
BRD | Director/Board Member | 63 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.01% | 9 M€ | +9.52% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 12.68 | -0.70% | 47 715 |
24-06-07 | 12.77 | -0.85% | 407,407 |
24-06-06 | 12.88 | -1.38% | 806,595 |
24-06-05 | 13.06 | +2.27% | 858,846 |
24-06-04 | 12.77 | -3.11% | 1,823,351 |
Delayed Quote Nasdaq, June 10, 2024 at 09:54 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.22% | 1.12B | |
+47.23% | 57.87B | |
+40.60% | 40.25B | |
-6.74% | 39.94B | |
-5.16% | 28.54B | |
+11.13% | 26.4B | |
-20.57% | 19.33B | |
+30.53% | 12.4B | |
-1.53% | 12.23B | |
+23.25% | 12.2B |
- Stock Market
- Equities
- DAWN Stock